Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rimsza

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
Haematologica|April 10, 2010
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphomaChristopher J Stasik, Hiroaki Nitta, Wenjun Zhang, et al.
Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.
American Journal of Clinical Pathology|December 28, 2020
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline DisordersKatalin Kelemen, Leonie Saft, Fiona E Craig, et al.
Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.
Inorganic Chemistry|August 22, 2018
Synthesis, Characterization, and Nanomaterials Generated from 6,6'-(((2-Hydroxyethyl)azanediyl)bis(methylene))bis(2,4-di- tert-butylphenol) Modified Group 4 Metal AlkoxidesTimothy J Boyle, Joshua Farrell, Daniel T Yonemoto, et al.
Leukemia & Lymphoma|January 14, 2016
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520Soham D Puvvada, Hongli Li, Lisa M Rimsza, et al.
British Journal of Haematology|October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601Brian G Till, Hongli Li, Steven H Bernstein, et al.
Cancer Research|May 29, 2015
Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ TumorsAmit Dipak Amin, Soumya S Rajan, Winnie S Liang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphomaRobin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Haematologica|April 10, 2010
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphomaChristopher J Stasik, Hiroaki Nitta, Wenjun Zhang, et al.
Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.
American Journal of Clinical Pathology|December 28, 2020
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline DisordersKatalin Kelemen, Leonie Saft, Fiona E Craig, et al.
Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.
Inorganic Chemistry|August 22, 2018
Synthesis, Characterization, and Nanomaterials Generated from 6,6'-(((2-Hydroxyethyl)azanediyl)bis(methylene))bis(2,4-di- tert-butylphenol) Modified Group 4 Metal AlkoxidesTimothy J Boyle, Joshua Farrell, Daniel T Yonemoto, et al.
Leukemia & Lymphoma|January 14, 2016
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520Soham D Puvvada, Hongli Li, Lisa M Rimsza, et al.
British Journal of Haematology|October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601Brian G Till, Hongli Li, Steven H Bernstein, et al.
Cancer Research|May 29, 2015
Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ TumorsAmit Dipak Amin, Soumya S Rajan, Winnie S Liang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphomaRobin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
Pageof 21